Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-27T08:33:57.591Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of an Inhibitor of Lipid Peroxidation, U78517F, on C6 Astrocytoma Growth

Published online by Cambridge University Press:  18 September 2015

Rolando F. Del Maestro ,
Christine R. Farrell ,
Eric Stroude  and
Warren McDonald
Rolando F. Del Maestro*
Affiliation:
Brain Research Laboratories, Experimental Research Unit, Department of Clinical Neurological Sciences, University of Western Ontario, Victoria Hospital, London, Ontario
Christine R. Farrell
Affiliation:
Brain Research Laboratories, Experimental Research Unit, Department of Clinical Neurological Sciences, University of Western Ontario, Victoria Hospital, London, Ontario
Eric Stroude
Affiliation:
Brain Research Laboratories, Experimental Research Unit, Department of Clinical Neurological Sciences, University of Western Ontario, Victoria Hospital, London, Ontario
Warren McDonald
Affiliation:
Brain Research Laboratories, Experimental Research Unit, Department of Clinical Neurological Sciences, University of Western Ontario, Victoria Hospital, London, Ontario
*
Brain Research Laboratories, Victoria Hospital, 375 South Street, London, Ontario, Canada N6A 4G5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A potent in vitro inhibitor of lipid peroxidation, U78517F, has been employed to assess its influence on C6 astrocytoma growth in monolayer culture and tumor growth and protein extravasation in the rat C6 astrocytoma spheroid implantation model. Results demonstrate that 1 μM concentration of U78517F inhibits cell division, but is not tumoricidal to C6 astrocytoma cells in monolayer culture. Concentrations of 5 μM and above significantly decreased astrocytoma cell viability. Following spheroid implantation, rats were treated with one of these U785I7F regimes: 12 mg/kg/day for 13 days post-implantation, 4 mg/kg/day for 13 days post-implantation or 12 mg/kg/day commencing seven days post-implantation until 13 days post-implantation. Tumor wet and dry weights were lower in all treatment groups, but these decreases were not statistically significant. Protein extravasation as measured by Evans blue extravasation was not significantly reduced by any treatment regime used. It is concluded that U78517F inhibits C6 astrocytoma growth in monolayer culture at and above 5 μM concentrations, but the treatment regimes utilized did not significantly decrease tumor growth or permeability in the C6 astrocytoma spheroid implantation model.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 18 , Issue 1 , February 1991 , pp. 7 - 11
Copyright
Copyright © Canadian Neurological Sciences Federation 1991

References

1.Barkowsky, HM. Peritumoral edema. Prog Exp Tumor Res 1984; 27: 179–190.CrossRefGoogle Scholar
2.Del Maestro, RF, Megyesi, JF, Farrell, CI. Mechanisms of tumorassociated edema: A review. Can J Neurol Sci 1990; 17: 177–183.CrossRefGoogle ScholarPubMed
3.Stewart, PA, Hayakawa, K, Farrell, CL, et al. Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for blood-brain barrier defect. J Neurosurg 1987; 67: 697–705.CrossRefGoogle ScholarPubMed
4.Coomber, B, Stewart, PA, Hayakawa, F, et al. Quantitative morphology of glioblastoma multiforme microvessels. Structural basis of blood-brain barrier defect. J Neuro-Oncol 1987; 5: 299–307.Google ScholarPubMed
5.Auer, R, Del Maestro, RF, Andersen, R, A simple and reproducible experimental in vivo glioma model. Can J Neurol Sci 1981; 8: 325–331.CrossRefGoogle ScholarPubMed
6.Farrell, CL, Stewart, PA, Del Maestro, RF, A new glioma model in rat: The C6 astrocytoma implantation technique permeability and vascular characterization. J Neuro-Oncol 1987; 4: 403–415.Google ScholarPubMed
7.Stewart, PA, Hayakawa, K, Hayakawa, E, et al. A quantitative study of blood-brain barrier permeability ultrastructure in a new glioma model. Acta Neuropathol(Bed) 1985; 67: 96–102.CrossRefGoogle Scholar
8.Reichman, HR, Farrell, CL, Del Maestro, RF, Effects of steroids and nonsteroidal anti-inflammatory agents on vascular permeability in a rat glioma model. J Neurosurg 1986; 65: 233–237.Google Scholar
9.Farrell, CL, Megyesi, JF, Del Maestro, RF, Effect of ibuprofen on tumor growth in the C6 spheroid implantation glioma model. J Neurosurg 1988; 68: 925–930.CrossRefGoogle ScholarPubMed
10.Shinonaga, M, Chang, CC, Suzuki, N, et al. Immunohistological evaluation of macrophage infiltrates in brain tumors. J Neurosurg 1988; 68: 259–265.CrossRefGoogle ScholarPubMed
11.Del Maestro, RF, Thaw, HH, Bjork, J, et al. Free radicals as mediators of tissue injury. Acta Physiol Scand Suppl 1980; 492: 43–57.Google ScholarPubMed
12.Del Maestro, RF, Free radicals as mediators of tissue injury. In: Dreosti, 1, ed. Trace Elements, Micronutrients and Free Radicals (In Press).Google Scholar
13.Del Maestro, RF, Role of superoxide anion radicals in microvascular permeability and leukocyte behaviour. Can J Physiol Pharmacol 1982; 60: 1406–1414.Google ScholarPubMed
14.Del Maestro, RF, An approach to free radicals in medicine and biology. Acta Physiol Scand Suppl 1980; 492: 153–168.Google ScholarPubMed
15.Johnson, KJ, Ward, PA, Inflammation and active oxygen species. In: Oberley, LW, ed. Superoxide Dismutase Vol. 3: Boca Raton: CRC Press 1985; 129–142.Google Scholar
16.Braughler, JM, Pregenzer, JF, Chase, RL, et al. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987; 262: 10438–10440.Google ScholarPubMed
17.Hall, ED, Pazara, KE, Braughler, JM, 21-amino steroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils. Stroke 1988; 19: 997–1002.CrossRefGoogle Scholar
18.Hall, ED, Yonkers, PA, Attenuation of post-ischemic cerebral hypoperfusion by the 21-amino steroid U74006F. Stroke 1988; 19: 340–344.Google Scholar
19.Hall, ED, Yonkers, PA, McCall, JM, et al. Effects of the 21-amino steroid U74006F on experimental head injury in mice. J Neurosurg 1988; 68: 456–461.CrossRefGoogle Scholar
20.Hall, ED, Effects on the 21-amino steroid U74006F on posttraumatic spinal cord ischemia. J Neurosurg 1988; 68: 462–465.CrossRefGoogle Scholar
21.Zuccarello, M, Anderson, DK. Protective effect of a 21 -amino steroid on the blood-brain barrier following subarachnoid hemorrhage in rats. Stroke 1989; 20: 367–371.CrossRefGoogle Scholar
22.Megyesi, JF, Farrell, CL, Del Maestro, RF. Investigation of an inhibitor of lipid peroxidation U74006F on tumor growth and protein extravasation in the C6 astrocytoma spheroid implantation glioma model. J Neuro-Oncol 1990; 8: 133–137.CrossRefGoogle ScholarPubMed
23.Hall, ED, Braughler, JM, Yonkers, PA, et al. U78517F, a second generation lazaroid with potent antioxidant and cerebroprotective activity in models of CNS injury and ischemia. J Neurotrauma 1989; 6: 213–214.Google Scholar
24.Lordo, CD, Stroude, EC, Del Maestro, RF. The effects of diphenylhydantoin on murine astrocytoma radiosensitivity. J Neuro-Oncol 1987; 5: 339–350.CrossRefGoogle ScholarPubMed
25.Lordo, CD, Stroude, ED, Del Maestro, RF. The effects of dexamethasone on C6 astrocytoma radiosensitivity. J Neurosurg 1989; 70: 767–773.Google ScholarPubMed